Role of NFAT and NFAT-Induced Genes in Carcinoma
Role of NFAT and NFAT-Induced Genes in Carcinoma
批准号:
8448239
负责人:
Alex Toker
金额:
$27.75万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2015-03-31
关键词:
ActinsAllelesAntineoplastic AgentsAutocrine CommunicationBehaviorBiochemicalBiological AssayBreast Cancer CellCCRCXCRCXCR4 geneCancer EtiologyCancer cell lineCandidate Disease GeneCarcinomaCell Surface ReceptorsCell SurvivalCharacteristicsCoupledCytoskeletonDataDevelopmentDistantEpithelialEpithelial CellsEtiologyFamilyFundingFutureGene TargetingGenesGlycogen Synthase Kinase 3GlypicanGoalsHeparan Sulfate ProteoglycanHumanImmigrationIn VitroIntegrinsKnowledgeLigandsMalignant Epithelial CellMalignant NeoplasmsMammary NeoplasmsMediatingMolecularMolecular GeneticsNFAT PathwayNatureNeoplasm MetastasisOrganOutcomeParacrine CommunicationPathway interactionsPeptide HydrolasesPhasePhenotypePhysiologicalPlayProtein IsoformsProteinsPublishingReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationRoleSignal PathwaySignal TransductionTestingTherapeutic InterventionXenograft procedureabstractingbasecancer cellcell motilitychemokinechemokine receptorcyclooxygenase 2defined contributiondesigneffective therapygene inductionin vivoin vivo Modelinsightmalignant breast neoplasmmatrigelmigrationneoplastic cellresearch studyresponsescreeningsmall hairpin RNAsuccesstooltranscription factortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The objective of this application is to define the mechanisms by which the NFAT transcription factor
promotes breast cancer cell invasive migration. Specifically, we will focus on the signaling pathways stimulated
by genes induced by NFAT and which promote invasive migration. Studies in the previous funding period
showed that NFAT is a critical transcription factor in cancer cells as it promotes both the motility and invasion
of carcinoma cells. We showed that the ¿6¿4 integrin is one important upstream regulatory mechanism leading
to NFAT activation, and also published the role of Akt/PKB and GSK-3 in NFAT regulation. Little is known,
however, concerning the array of genes induced by NFAT, and how in turn these genes control invasive
migration. Recent published and preliminary studies have provided evidence that COX-2 (cyclooxygenase-2) is
an NFAT-induced gene which promotes carcinoma invasion. We have further identified two families of cell
surface receptors, chemokine receptors and glypicans (heparan sulfate proteoglycans) which are induced by
NFAT, and studies show that they promote invasive migration. We propose the hypothesis that NFAT
promotes invasive migration by inducing paracrine and autocrine signaling pathways whereby both chemokine
ligands, chemokine receptors and glypicans are critical modulators of this phenotype. There is near complete
paucity of knowledge concerning the nature of genes induced by NFAT in cancer, and our studies take a
discovery-based approach to identify, characterize and investigate in detail the molecular mechanisms by
which transcriptional responses induced by NFAT modulate cancer cell signaling. Our overall hypothesis will
be tested in 2 specific Aims.:-
In AIM 1 we will test the contribution chemokine receptors and chemokines induced by NFAT in breast
cancer cells. We will determine the contribution of chemokine receptors including CXCR-2, CCR-2, XCR-1 and
CXCR4 and their ligands in NFAT-mediated invasion, and the role of paracrine and autocrine signaling.
In AIM 2, we will determine the mechanism by which NFAT induces glypican-6 (GPC6) expression. We will
determine how NFAT and GPC6 promote invasive migration in vitro and in vivo, and investigate the
mechanisms by which GPC6 collaborates with Wnt signaling.
The results of these studies will provide important new insights into the mechanisms by which NFAT
modulates cancer cell invasive migration through induction of critical target genes. We anticipate that
continuation of our NFAT studies will provide important new information in the field because they will highlight
new mechanisms of modulation of cancer progression. There is also the potential that the outcome of our
studies will provide for the future development of therapeutic interventions for tumor progression.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.advenzreg.2011.09.020
发表时间:
2012-01
期刊:
Advances in biological regulation
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1038/nrc2735
发表时间:
2009-11
期刊:
NATURE REVIEWS CANCER
影响因子:
78.5
作者:
[Mancini, Maria, Toker, Alex]
通讯作者:
Toker, Alex
DOI:
10.1158/0008-5472.can-09-4231
发表时间:
2010-10-15
期刊:
Cancer research
影响因子:
11.2
作者:
[Fry JL, Toker A]
通讯作者:
Toker A
FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
-
批准号:10464756
-
项目类别:
-
资助金额:$0.35万
-
财政年份:2022
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10246864
-
项目类别:
-
资助金额:$103.5万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10677761
-
项目类别:
-
资助金额:$97.51万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10471296
-
项目类别:
-
资助金额:$100.84万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
-
批准号:9903255
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:Alex Toker
-
依托单位:
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
-
批准号:9270532
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:Alex Toker
-
依托单位:
Identifying lincRNAs that Mediate PI 3 Kinase Dependent Breast Cancer
-
批准号:8610428
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2014
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:9812868
-
项目类别:
-
资助金额:$41.56万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8870311
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8559337
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8702122
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
FASEB Summer Research Conference on Lipid Signaling Pathways in Cancer
-
批准号:7329084
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:8024499
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7256658
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7579113
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7388910
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7772392
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6604523
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6910034
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of NFAT and NFAT-Induced Genes in Carcinoma
-
批准号:8055453
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
海外基金